Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-14
DOI
10.1038/s41591-021-01507-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Diagnosis and Treatment of Multiple Sclerosis
- (2021) Marisa P. McGinley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dynamic regulation of TFH selection during the germinal centre reaction
- (2021) Julia Merkenschlager et al. NATURE
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
- (2021) Rémy Duléry et al. AMERICAN JOURNAL OF HEMATOLOGY
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
- (2021) Erin M. Bange et al. NATURE MEDICINE
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity
- (2020) Anna B. Morris et al. IMMUNITY
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- COVID-19 in multiple sclerosis: The Dutch experience
- (2020) Floor C Loonstra et al. Multiple Sclerosis Journal
- Disease and healthcare burden of COVID-19 in the United States
- (2020) Ian F. Miller et al. NATURE MEDICINE
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- SARS-CoV-2 seroprevalence among parturient women in Philadelphia
- (2020) Dustin D. Flannery et al. Science Immunology
- The role of B cells in Multiple Sclerosis and related disorders
- (2020) Giancarlo Comi et al. ANNALS OF NEUROLOGY
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
- (2020) Ana Zabalza et al. EUROPEAN JOURNAL OF NEUROLOGY
- B cell depletion therapies in autoimmune disease: advances and mechanistic insights
- (2020) Dennis S. W. Lee et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- Antigen‐dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DC s
- (2019) Kanishka Mohib et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells
- (2019) Joanne Boldison et al. Cellular & Molecular Immunology
- Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets
- (2019) Anna C. Belkina et al. Nature Communications
- Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types
- (2018) Allison R. Greenplate et al. Cancer Immunology Research
- Features of Human CD3+CD20+T Cells
- (2016) Elisabeth Schuh et al. JOURNAL OF IMMUNOLOGY
- Earth Mover’s Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations
- (2016) Darya Y. Orlova et al. PLoS One
- FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
- (2015) Sofie Van Gassen et al. CYTOMETRY PART A
- B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus
- (2015) Josephine R. Giles et al. JOURNAL OF IMMUNOLOGY
- Circulating CXCR5+PD-1+Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults
- (2014) Ramin Sedaghat Herati et al. JOURNAL OF IMMUNOLOGY
- Inhibitory Fc Receptor Is Required for the Maintenance of Tolerance through Distinct Mechanisms
- (2014) F. Li et al. JOURNAL OF IMMUNOLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- B Cell Antigen Presentation in the Initiation of Follicular Helper T Cell and Germinal Center Differentiation
- (2014) L. G. Barnett et al. JOURNAL OF IMMUNOLOGY
- Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study
- (2014) Henning K Olberg et al. Multiple Sclerosis Journal
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Vaccination against infection in patients with multiple sclerosis
- (2012) Micha Loebermann et al. Nature Reviews Neurology
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
- (2008) Joseph D. Miller et al. IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started